A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Clinical trial NCT04857034 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04857034
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-12
- Primary completion
- 2024-08-22
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.